Vosevi Interactions
There are 237 drugs known to interact with Vosevi (sofosbuvir/velpatasvir/voxilaprevir), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 52 are major, 178 are moderate, and 7 are minor.
- View all 237 medications that may interact with Vosevi
- View Vosevi alcohol/food interactions (1)
- View Vosevi disease interactions (4)
Most frequently checked interactions
View interaction reports for Vosevi (sofosbuvir / velpatasvir / voxilaprevir) and the medicines listed below.
- Advate (antihemophilic factor)
- Daklinza (daclatasvir)
- Dupixent (dupilumab)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- Epclusa (sofosbuvir / velpatasvir)
- Esbriet (pirfenidone)
- Gleevec (imatinib)
- Harvoni (ledipasvir / sofosbuvir)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- Mavyret (glecaprevir / pibrentasvir)
- Moderiba (ribavirin)
- NovoSeven RT (coagulation factor viia)
- Ofev (nintedanib)
- Opdivo (nivolumab)
- Placidyl (ethchlorvynol)
- Procysbi (cysteamine)
- Prograf (tacrolimus)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- ribavirin
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecfidera (dimethyl fumarate)
- Tracleer (bosentan)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
Vosevi alcohol/food interactions
There is 1 alcohol/food interaction with Vosevi (sofosbuvir / velpatasvir / voxilaprevir).
Vosevi disease interactions
There are 4 disease interactions with Vosevi (sofosbuvir / velpatasvir / voxilaprevir) which include:
Report options
More about Vosevi (sofosbuvir / velpatasvir / voxilaprevir)
- Vosevi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret is used to treat adults and children 3 years of age and older with acute or chronic ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Zepatier
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C. Includes Zepatier side ...
Interferon alfa-2b
Interferon alfa-2b is used for angioblastoma, condylomata acuminata, conjunctival mucosa-associated ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
